Top News

Ambry Genetics Countersues Myriad Genetics




Aliso Viejo-based cancer and genetics testing providre Ambry Genetics said this morning that it is suing Myriad Genetics, in a response to a patent infringement lawsuit filed by Myriad and others against the company last month. Ambry Genetics claimed Myriad's patent lawsuit against the company is a violation of the Sherman Antitrust Act, and that Myriad is looking to monopolize testing of human BRCA1 and BRCA2 genes. Ambry said that Myriad's "anticompetitive conduct" means consumers have to pay "significantly higher prices" for cancer testing.


 

Marketplace


 

 

Latest Headlines

Browse Issues

 
 

Keep up with all of the latest Southern California high tech news via email (it's free!)



or Cancel